| abstract |
The present invention provides monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors. Kind Code: A1 Monocyclic or bicyclic carbocyclic and heterocyclic rings having the formula 1 and derivatives thereof, or pharmaceutically acceptable salts thereof, are used as inhibitors of Factor Xa. The monocyclic or bicyclic carbocyclic and heterocyclic rings of formula 1 and their derivatives, or their pharmaceutically acceptable salts, act as anticoagulants for the treatment and prevention of thromboembolism. . |